Bibliographic Details
| Title: |
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT. |
| Authors: |
Tarantino, Paolo, Tayob, Nabihah, Villacampa, Guillermo, Dang, Chau, Yardley, Denise A., Isakoff, Steven J., Valero, Vicente, Faggen, Meredith, Mulvey, Therese, Bose, Ron, Weckstein, Douglas, Wolff, Antonio C., Reeder-Hayes, Katherine, Rugo, Hope S., Ramaswamy, Bhuvaneswari, Zuckerman, Dan, Hart, Lowell, Gadi, Vijayakrishna K., Constantine, Michael, Cheng, Kit |
| Source: |
Journal of Clinical Oncology; 11/1/2024, Vol. 42 Issue 31, p3652-3665, 18p |
| Database: |
Supplemental Index |
